LI Medved’s Research Centre of Preventive Toxicology, Food and Chemical Safety, Ministry of Health, Ukraine (State Enterprise), Kyiv, Ukraine
ABSTRACT. The Aim of the Research. To analyse and summarize the data of modern literature on the use of rabbits for laboratory experimental studies and substantiate the prospects for their further use.
Materials and Methods. The analytical methods such as collection of scientific information on the problem, analysis of literature data from PubMed libraries as well as scientific generalization of the results obtained were used in the work.
Results and Conclusions. The principles of the prospects for the further use of rabbits for laboratory experimental studies have been substantiated. Thanks to certain scientific advances, ethical alternative scientific testing methods without the involvement of living beings have already been developed and implemented. Exactly these methods help to get more reliable results. If in some scientific research rabbits are no longer used, then in other directions on the contrary, every year the need to use these mammals for experimental studies increases. And there is a well-reasoned explanation for this. Currently, there is no alternative to using rabbits for the production of antibodies, recombinant proteins. Testing in laboratory animals is the best method for detecting phenomena such as cancer and birth defects. Genetically modified rabbits are a new perspective for scientific research. With the development of new technologies, editing the genome, especially CRISPR / Cas9 and its modifications, has made it possible with high efficiency to obtain a much larger number of transgenic animals with precisely specified genetic modifications for solving a wide variety of problems. The use of animals in experiments is critically important for some areas of scientific research because the complexity of the structure of an organism cannot be duplicated in cell culture or using computer models.
Key Words: rabbits, maintenance, testing on animals, human health.
REFERENCES
1. Bellón JM, Rodríguez M, Pérez‐Köhler B, Pérez‐López P, Pascual G. The New Zealand White Rabbit as a model for preclinical studies addressing tissue repair at the level of the abdominal wall. Tissue Eng Part C Methods. 2017;23:863–80.
2. Bosze ZS, Houdebine LM. Application of rabbits in biomedical research: a review. World Rabbit Sci. 2006;14:1–14.
3. Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol Exp Ther. 1944;82:377–90.
4. Daniel Morton. The Use of Rabbits in Male Reproductive Toxicology. Environmental Health Perspectives. 1988;77:5–9.
5. Duverger N, Kruth H, Emmanuel F, Caillaud JM, Viglietta C, Castro G, et al. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-1 transgenic rabbits. Circulation. 1996;94:713–17.
6. Fisher PG. Standards of care in the 21st century: the rabbit. J Exot Pet Med. 2010;19:22–35.
7. Franco NH. Animal experiments in biomedical research: a historical perspective. Animals. 2013;3:238–73.
8. Harkness JE, Wagner JE. The biology and medicine of rabbits and rodents (2nd Ed.). Lea & Febiger. 1983.
9. Dzherelo dostupu: тhttps://www.toxicology.org/pubs/docs/air/AIR_Final.pdf
10. Hui JH, Chan SW, Li J, et al. Intra‐articular delivery of chondroitin sulfate for the treatment of joint defects in rabbit model. J Mol Histol. 2007;38:483–489.
11. Hunt CE, Harrington DD, Weisbroth SH, Flatt RE, Kraus AL. Nutrition and nutritional diseases of the rabbit. In: The Biology of the Laboratory Rabbit. New York Academic Press: NY;1974,403–33.
12. Dzherelo dostupu: ISO 10993 – 10: 2002.
13. Kondo M, Sakai T, Komeima K, Kurimoto Y, Ueno S, Nishizawa Y, et al. Generation of a transgenic rabbit model of retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2009;50:1371–7. doi: 10.1167/iovs.08-2863
14. Llebenberg SP, Linn JM. Seasonal and sexual influences on rabbit atropinesterase. Lab Anim. 1980;14:297–300.
15. Lv Q, Yuan L, Deng J, Chen M, Wang Y, Zeng J, et al. Efficient generation of myostatin gene mutated rabbit by CRISPR/Cas9. Sci. Rep. 2016;6:25029. doi:10.1038/srep25029.
16. Oki Y, Doi K, Makihara Y, Kobatake R, Kubo T, Tsuga K. Effects of continual intermittent administration of parathyroid hormone on implant stability in the presence of osteoporosis: an in vivo study using resonance frequency analysis in a rabbit model. J Appl Oral Sci. 2017;25:498–505.
17. Pasteur L. Méthode pour prévenir la rage après morsure. C. R. T. 1885;101:765–72.
18. Refinements in rabbit husbandry. SECOND REPORT OF THE BVAAWF/FRAME/RSPCA/UFAW JOINT WORKING GROUP ON REFINEMENT. Laboratory Animals 1993;27:301–29.
19. Sayers I. Approach to preventive health care and welfare in rabbits. In Pract. 2010;32:190–8.
20. Sharpe R. The Draize test-motivations for change. Fd Chem Toxicol 1985;23:139–43.
21. Suckow Mark A, Brammer David W, Rush Howard G, Chrisp Clarence E. "Biology and Diseases of Rabbits." Chapter 9 in Laboratory Animal Medicine, 2nd Edition. James G. Fox, et al, editors. New-York: Academic Press; 2002.
22. Sui T, Xu L, Lau YS, Liu D, Liu T, Gao Y, et al. Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations. Cell Death Dis. 2018;9:609.
23. Wang Y, Niimi M, Nishijima K, Waqar AB, Yu Y, Koike T, et al. Human apolipoprotein A-II protects against dietinduced atherosclerosis in transgenic rabbits. Arterioscler. Thromb. Vasc. Biol. 2013;33:224–31. doi: 10.1161/ATVBAHA. 112.300445
24. Weber J, Peng H, Rader C. From rabbit antibody repertoires to rabbit monoclonal antibodies. Exp. Mol. Med. 2017;49:305. doi: 10.1038/emm.2017.23.
25. Yanni AE. The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim. 2004;38:246–56.
Received 03/17/2021